558442-96-9

Basic information

• Product Name: tert-butyl ((1r,4r)-4-Morpholinocyclohexyl)carbaMate
• Synonyms: tert-butyl ((1r,4r)-4-Morpholinocyclohexyl)carbaMate;tert-Butyl (trans-4-morpholinocyclohexyl)carbamate
• CAS NO: 558442-96-9
• Molecular Formula: C₁₅H₂₈N₂O₃
• Molecular Weight: 284.39442
• Mol File: 558442-96-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 396.3±37.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 12.50±0.40(Predicted)
• CAS DataBase Reference: tert-butyl ((1r,4r)-4-Morpholinocyclohexyl)carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl ((1r,4r)-4-Morpholinocyclohexyl)carbaMate(558442-96-9)
• EPA Substance Registry System: tert-butyl ((1r,4r)-4-Morpholinocyclohexyl)carbaMate(558442-96-9)

Safety Data

• Hazardous Substances Data: 558442-96-9(Hazardous Substances Data)

Upstream product

• 2615-25-0 trans-1,4-cyclohexyldiamine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 111-44-4 3-oxa-1,5-dichloropentane 
• 177906-48-8 trans-N-Boc-1,4-cyclohexanediamine 
• 5414-19-7 1,1'-oxybis(2-bromo-ethane) 
• 195314-59-1 tert-butyl (4-aminocyclohexyl)carbamate 

Downstream Products

• 558442-97-0 (1r,4r)-4-(morpholin-4-yl)cyclohexan-1-amine 
• 1447952-43-3 2-(3-[[4-(morpholin-4-yl)cyclohexyl]amino]-8-thia-4,6,12-triazatricyclo[7.4.0.0[2,7]]trideca-1⁽⁹⁾,2⁽⁷⁾,3,5-tetraene-12-sulfonyl)ethan-1-ol 
• 1447952-41-1 12-(ethanesulfonyl)-N-[4-(morpholin-4-yl)cyclohexyl]-8-thia-4,6,12-triazatricyclo[7.4.0.0[2,7]]trideca-1⁽⁹⁾,2⁽⁷⁾,3,5-tetraen-3-amine 
• 1447952-37-5 1-(3-[[4-(morpholin-4-yl)cyclohexyl]amino]-8-thia-4,6,12-triazatricyclo[7.4.0.0[2,7]]trideca-1⁽⁹⁾,2⁽⁷⁾,3,5-tetraen-12-yl)ethan-1-one 
• 1447957-54-1 C₂₂H₃₀N₄O₄S 
• 1447957-55-2 C₂₀H₂₅N₄O₄S^(1-)*Li⁽¹⁺⁾ 
• 1447956-89-9 C₂₇H₃₃N₅O₃S 
• 1447956-90-2 C₁₉H₂₇N₅OS 
• 1447956-84-4 C₂₂H₃₁N₅O₅S₂ 
• 1447953-29-8 4-(((1r,4r)-4-morpholinocyclohexyl)amino)-6,8-dihydro-5H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidine-6-carboxamide 
• 1447952-70-6 [(12S)-3-[[4-(morpholin-4-yl)cyclohexyl]amino]-8-thia-4,6-diazatricyclo[7.4.0.0[2,7]]trideca-1⁽⁹⁾,2,4,6-tetraen-12-yl]methanol 
• 412356-24-2 (1r,4r)-4-(morpholin-4-yl)cyclohexan-1-amine dihydrochloride 

Relevant articles and documents

TREATMENT OF CDK4/6 INHIBITOR RESISTANT NEOPLASTIC DISORDERS

This invention is to methods for treating disorders involving abnormal cellular proliferation that have developed resistance to a selective CDK4/6 inhibitor.

Solid dispersions containing an apoptosis-inducing agent

A pro-apoptotic solid dispersion comprises, in essentially non-crystalline form, a Bcl-2 family protein inhibitory compound of Formula I as defined herein, dispersed in a solid matrix that comprises (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. A process for preparing such a solid dispersion comprises dissolving the compound, the polymeric carrier and the surfactant in a suitable solvent, and removing the solvent to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. The solid dispersion is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.